Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.

Feng, Sijie; Wang, Zhenhui; Zhang, Huizhen; Hou, Baohua; Xu, Yanjun; Hao, Shuangying; Lu, Yunkun

Feng, Sijie; Wang, Zhenhui; Zhang, Huizhen; Hou, Baohua; Xu, Yanjun; Hao, Shuangying; Lu, Yunkun.

Affiliation

Feng S; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
Wang Z; Jiaozuo Key Laboratory of Gynecological Oncology Medicine, Jiaozuo, China.
Zhang H; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
Hou B; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
Xu Y; School of Medicine, Henan Polytechnic University, Jiaozuo, China.
Hao S; Department of Medical Thoracic Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Lu Y; School of Medicine, Henan Polytechnic University, Jiaozuo, China.

J Gene Med ; 26(1): e3643, 2024 Jan.

Article de En | MEDLINE | ID: mdl-38044747

Sujet(s)
Mots clés

cervical squamous cell carcinoma; chemotherapeutic drug; prognosis; programmed cell death; tumor immune microenvironment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome épidermoïde / Tumeurs du col de l'utérus Limites: Female / Humans Pays/Région comme sujet: America do norte Langue: En Journal: J Gene Med Sujet du journal: BIOLOGIA MOLECULAR / GENETICA MEDICA Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google